Literature DB >> 3259244

Direct resolution of the stereoisomers of leucovorin and 5-methyltetrahydrofolate using a bovine serum albumin high-performance liquid chromatographic chiral stationary phase coupled to an achiral phenyl column.

I W Wainer1, R M Stiffin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3259244     DOI： 10.1016/s0378-4347(00)81088-9

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  6 in total

1.  Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue.

Authors:  C Wolfrom; R Hepp; R Hartmann; H Breithaupt; G Henze
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Pharmacokinetics of reduced folates after short-term infusion of d, 1-folinic acid.

Authors:  A Schalhorn; M Kühl; G Stupp-Poutot; V Nüssler
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Pharmacokinetic and pharmacodynamic comparison of two doses of calcium folinate combined with continuous fluorouracil infusion in patients with advanced colorectal cancer.

Authors:  S Stremetzne; M Streit; E D Kreuser; W Schunack; U Jaehde
Journal:  Pharm World Sci       Date:  1999-08

4.  Pharmacokinetic comparison of leucovorin and levoleucovorin.

Authors:  J Zittoun; A P Tonelli; J Marquet; E De Gialluly; C Hancock; A Yacobi; J B Johnson
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Column-switching high-performance liquid chromatography for on-line simultaneous determination and resolution of enantiomers of verapamil and its metabolites.

Authors:  Y Oda; N Asakawa; T Kajima; Y Yoshida; T Sato
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

6.  The pharmacokinetics of reduced folates after intraperitoneal and intravenous administration of racemic [6S,R]-folinic acid.

Authors:  J H Sips; O van Tellingen; W J Nooijen; S Rodenhuis; W J Ten Bokkel Huinink; J H Beijnen
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.